Items tagged with Diagnostics
Tuberculin Skin Test (image)
The Tuberculin Skin Test involves injecting attenuated TB bacteria into the arm. If there is a reaction after a few days, then it is likely the person has latent TB.
SURABAYA (February 11, 2014) – In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and Company (BD), a leading global medical technology company, announced today a collaboration to strengthen Indonesia’s national reference laboratory systems. This new private/public partnership supports the National Tuberculosis (TB) Program (NTP), and will aim to improve and expand quality laboratory services. In particular, the collaboration will emphasize the early detection of TB cases, as well as monitoring and treatment services.
Frost & Sullivan applauds GBDbio's disruptive TB REaD™ POC diagnostics specifically for developing countries (post)
By creating a product that precisely mirrors the needs and requirements of the market, GBDbio has been successful in gaining buy-ins from the key players to ensure a running start
With 9 million new cases and 2 million deaths annually, tuberculosis is the second most prevalent and deadliest infectious disease worldwide. As an airborne disease, it spreads easily and is very contagious. Quick detection and identification is the key to success in preventing the spread of the disease.
HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.
CROI 2014: GeneXpert real world study yields mixed results, highlights SA health system challenges (post)
BOSTON, MASS – Gavin Churchyard and Katherine Fielding presented results this morning from the XPert for TB: Evaluating a New Diagnostic Trial (EXTEND) on the question of whether Xpert MTB/RIF diagnostic test reduces early mortality in adults with suspected TB, facilitates earlier initiation of TB treatment and antiretroviral therapy and reduces the number of patients lost to follow up compared to sputum microscopy.
BOSTON — Replacing smear microscopy with the Xpert MTB/RIF test did not decrease mortality among people with suspected tuberculosis in South Africa, according to study results presented at the 2014 Conference on Retroviruses and Opportunistic Infections.
Boulder, CO, March 11, 2014 – MBio Diagnostics, Inc. presented results last week of a study entitled "Highly Multiplexed Detection of Antibodies in Whole Blood during Tuberculosis Infection" at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, MA. MBio is collaborating with the Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, on a program aimed at developing a simple, point-of-care blood test for active tuberculosis disease (TB) using MBio's multiplexed immunoassay platform.
Enigma Diagnostics, a leader in molecular diagnostic point-of-care infectious disease testing, announces that it has been awarded a second grant from the UK’s innovation agency, the Technology Strategy Board. This grant will support further development of its test for multidrug-resistant tuberculosis (MDR-TB) on its CE Marked Enigma® Mini Laboratory (ML) system.
India accounts for a quarter of the 8.6 million cases of TB that occur worldwide. India also accounts for a third of the ‘missing 3 million TB cases’ that do not get diagnosed or notified. Not only is TB not going away, we are now seeing severe forms of multidrug-resistant TB (MDR-TB).
Page 1 of 36 · Total posts: 01 2 Last→